Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.14
+0.79 (0.35%)
AAPL  271.74
-1.93 (-0.71%)
AMD  214.82
+1.39 (0.65%)
BAC  56.03
+0.76 (1.38%)
GOOG  310.63
+2.02 (0.65%)
META  658.50
-0.27 (-0.04%)
MSFT  486.09
+0.17 (0.03%)
NVDA  183.12
+2.13 (1.18%)
ORCL  196.34
+4.37 (2.28%)
TSLA  494.70
+13.50 (2.81%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.